Liberals Were Just Dying to Share This Talking Point Last Night
The Crusty Commies Are a Joke
Barack Obama Doing This Behind the Scenes Confirms Again That Kamala Was a...
Lawn Gone Liberty: The Update
Deportation Dysphoria in the Press, and MSNBC Loses Its Star Statistician
Jeffrey Goldberg Congratulates Himself All Over PBS
Shut Down the Department of Education ASAP
Why National Concealed Carry Reciprocity Will Make Americans Safer
Self-Destructive Democracies
The President Who Set the Precedent Against a Third Term
Roadmap to Reform CDC -- Currently the Centers for Disaster and Confusion
Progressives Are Well Organized, Patriotic Americans Have to Do It Even Better
Supreme Court’s Getting Busy
Lawmakers Shouldn’t Let Bad Actors Get Away With Harming Children Online
Where Are the Left’s Protests Now?
Tipsheet

Biden Quietly Extends Covid 'Emergency Declaration' to Protect Big Pharma From Liability Until 2029

AP Photo/Mark Lennihan, File

The Biden Administration quietly rushed to extend the “Emergency Declaration” under the Public Readiness and Emergency Preparedness (PREP) Act until December 31, 2029, to protect Big Pharma and mRNA vaccine makers from lawsuits for injuries and deaths. The act also provides immunity from liability to healthcare providers, nurses, pharmacists, pharmacy interns, and pharmacy technicians who administered the COVID-19 vaccines. 

Advertisement

Xavier Becerra, the secretary of Health and Human Services (HHS), signed the 12th amendment to the declaration under the PREP Act for COVID-19 Medical Countermeasures, claiming the move was necessary because of a still substantial “credible risk” the pandemic spirals out of control in the next four years— or while President-elect Donald Trump is in office.  

According to the Federal Registrar Notice: 

I am now amending section XII of the Declaration to extend the time period of PREP Act coverage through December 31, 2029. COVID-19 continues to present a credible risk of a future public health emergency. 

COVID-19 continues to cause significant serious illness, morbidity, and mortality during outbreaks. The risk of domestic cases is high due to ongoing outbreaks that continue domestically and internationally in the year since the PHE for COVID-19 ended.

Development of and stockpiling vaccines, therapeutics, devices, and diagnostics for COVID-19 continues to be needed for U.S. preparedness against the credible threat of a public health emergency due to outbreaks of COVID-19. Continued coverage under the PREP Act, as provided in this Declaration, is intended to prepare for and mitigate the credible risk presented by COVID-19. 

The PREP Act, enacted in 2020, was initially intended to encourage vaccine manufacturers to speed up their research on COVID-19 vaccines without fear of being legally held responsible for side effects. The Biden Administration defended the sudden move, saying the extension would be a precaution for “future public health emergencies.” 

Advertisement

Michael Hogue, CEO of the American Pharmacists Association, said the extension would “continue saving lives and lower healthcare costs, particularly in rural and underserved areas where the local pharmacy may be the only healthcare provider for miles.” 

Per CDC data, about one in every 200,000 cases, a person will have an allergic reaction or suffer from heart problems, such as myocarditis or pericarditis, in response to a COVID-19 vaccine. The Daily Mail noted that there have been about 13,000 claims that the Covid vaccine or other related treatments have caused injury, with 10,000 of those awaiting review. This means that since 2020, only 3,000 of those claims have been reviewed. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement